Imminent FDA Approval of Addictive Ketamine for Depression Brings Back Echoes from the Opiate Epidemic

[In The News]

WEST ORANGE, N.J., March 4, 2019 /PRNewswire/ -- FDA's approval of ketamine to address depression classified as 'treatment resistant' is a double-edged sword. "Ketamine is currently used as an anesthetic, but it is also an abusable, addictive street drug," commented Indra Cidambi, M.D.,...

View the full article